Dupilumab With Concomitant Topical Corticosteroids in Atopic Dermatitis Patients Who Are Inadequately Controlled With or Medically Inadvisable for Cyclosporine A: A Phase 3 Clinical Trial (LIBERTY AD CAFE). J of Skin 2017, 1 (3.1), s37. https://doi.org/10.25251/skin.1.supp.36.